JORGE CASTILLO to Antiretroviral Therapy, Highly Active
This is a "connection" page, showing publications JORGE CASTILLO has written about Antiretroviral Therapy, Highly Active.
Connection Strength
1.324
-
Human immunodeficiency virus-associated lymphomas in the antiretroviral therapy era: Analysis of the National Cancer Data Base. Cancer. 2016 09 01; 122(17):2689-97.
Score: 0.462
-
Outcomes of HIV-associated Hodgkin lymphoma in the era of antiretroviral therapy. AIDS. 2016 Mar 13; 30(5):787-96.
Score: 0.453
-
Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy. Cancer. 2012 Nov 01; 118(21):5270-7.
Score: 0.086
-
Rituximab in combination with chemotherapy versus chemotherapy alone in HIV-associated non-Hodgkin lymphoma: a pooled analysis of 15 prospective studies. Am J Hematol. 2012 Mar; 87(3):330-3.
Score: 0.085
-
Prognostic factors in patients with HIV-associated peripheral T-cell lymphoma: a multicenter study. Am J Hematol. 2011 Mar; 86(3):256-61.
Score: 0.080
-
Management of HIV-associated lymphomas. Med Health R I. 2011 Jan; 94(1):4-6.
Score: 0.079
-
Non-AIDS defining cancers. Med Health R I. 2010 Oct; 93(10):296-8.
Score: 0.078